Related Experiment Video

Updated: Jun 21, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.4K

Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient

Jennifer E Marvin1, Paul Albert Trubin2, Marwan M Azar2,3

  • 1Department of Pharmacy, Yale New Haven Hospital, New Haven, Connecticut, USA.

Transplant Infectious Disease : an Official Journal of the Transplantation Society
|July 7, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
combination therapycytomegaloviruskidney transplant

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.7K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Related Experiment Videos

Last Updated: Jun 21, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

12.4K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.7K
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.2K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K

Articles linked to this work by shared authors, journal, and citation graph.

Nocardiosis in Immunocompromised Hosts: A Retrospective, Single-Center Analysis of Clinical and Microbiological Determinants of Central Nervous System Involvement.

Transplant infectious disease : an official journal of the Transplantation Society·2026

A mixed-methods study assessing the performance of a clinical decision support tool for Clostridioides difficile testing for patients receiving laxatives.

Infection control and hospital epidemiology·2025

Atypical pneumonia testing in transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2024

Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients.

Transplant infectious disease : an official journal of the Transplantation Society·2024

Rapid antimicrobial resistance detection methods for bloodstream infection in solid organ transplantation: Proposed clinical guidance, unmet needs, and future directions.

Transplant infectious disease : an official journal of the Transplantation Society·2023

Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors.

Open forum infectious diseases·2023

Pneumocystis jirovecii Pneumonia Outbreaks in Solid Organ Transplant Recipients: A Systematic Review of Epidemiology, Transmission Dynamics, and Outbreak Investigations.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Letermovir in Refractory and Resistant CMV After Lung Transplantation: Therapeutic Potential and Emergence of Resistance.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Post-Pyloric Enteral Immunoglobulin for Treatment of Chronic Norovirus Diarrhea in Solid Organ Transplant Recipients: A Single Center Retrospective Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Cytomegalovirus Vaccines in Transplantation: History, Hurdles, and Hope.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Validation of Administrative Health Data for Identifying Cytomegalovirus Infection After Solid Organ Transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Serial Blood Microbiome Profiles in Kidney Transplant Recipients Reveal Evidence of Circulating Gut and Non-Gut Derived Microbial DNA.

Transplant infectious disease : an official journal of the Transplantation Society·2026

A Novel Sequential Regimen of Efgartigimod and Telitacicept as Fast-Acting Treatment for Impeding Crisis of MuSK-MG.

Immunity, inflammation and disease·2026

Advances in non-invasive monitoring of drug delivery for neurodegenerative disorders.

Expert review of medical devices·2026

[Retracted] (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.

Molecular medicine reports·2026

Encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the BECARE (GEM-2002) trial.

Neuro-oncology advances·2026

Advancing Membrane Technologies for Cancer Therapy and Environmental Health: Biomimetic Innovations, Smart Technologies, and Sustainable Translation.

ACS omega·2026

Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.

The Yale journal of biology and medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us